G
G. Hoffmann
Researcher at St. Joseph Hospital
Publications - 2
Citations - 63
G. Hoffmann is an academic researcher from St. Joseph Hospital. The author has contributed to research in topics: Hazard ratio & Taxane. The author has an hindex of 2, co-authored 2 publications receiving 58 citations.
Papers
More filters
Journal ArticleDOI
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
U. Nitz,U. Nitz,Oleg Gluz,Jens Huober,Hans Kreipe,Ronald E. Kates,A. Hartmann,Ramona Erber,Michael Scholz,B. Lisboa,Svjetlana Mohrmann,Volker Möbus,Doris Augustin,G. Hoffmann,E. Weiss,S. Böhmer,R. Kreienberg,A. du Bois,D. Sattler,C Thomssen,Marion Kiechle,Fritz Jänicke,D. Wallwiener,Nadia Harbeck,Walther Kuhn +24 more
TL;DR: EC-Doc significantly improved EFS and OS versus FEC in intermediate-risk BC (1-3 LNs) within all subgroups as defined by local pathology.
Journal ArticleDOI
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2− early breast cancer: WSG-AGO EC-Doc Trial
Oleg Gluz,Cornelia Liedtke,Jens Huober,Jens Huober,H. Peyro-Saint-Paul,Ronald E. Kates,Hans-Heinrich Kreipe,A. Hartmann,E Pelz,Ramona Erber,Svjetlana Mohrmann,Volker Möbus,Doris Augustin,G. Hoffmann,C Thomssen,Fritz Jänicke,Marion Kiechle,D. Wallwiener,Walther Kuhn,Ulrike Nitz,Nadia Harbeck +20 more
TL;DR: The high interobserver variability for histological grade and the still missing validation of Ki-67 preclude indicating or omitting adjuvant chemotherapy based on these single factors alone.